Related references
Note: Only part of the references are listed.Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study
Arvind Ganapati et al.
CLINICAL RHEUMATOLOGY (2021)
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
Xenofon Baraliakos et al.
RHEUMATOLOGY AND THERAPY (2021)
SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: 2 YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY
U. Kiltz et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M. Ward et al.
ARTHRITIS CARE & RESEARCH (2019)
AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS
Uta Kiltz et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Epidemiology of axial spondyloarthritis: an update
Runsheng Wang et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part I: Principles of the Management of Spondyloarthritis in Canada
Sherry Rohekar et al.
JOURNAL OF RHEUMATOLOGY (2015)
Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort
Mohamed Bedaiwi et al.
JOURNAL OF RHEUMATOLOGY (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS
Nisha N. Haroon et al.
BMJ OPEN (2014)
The LUNDEX, a new index of drug efficacy in clinical practice - Results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden
LE Kristensen et al.
ARTHRITIS AND RHEUMATISM (2006)
Share Paper
